502 related articles for article (PubMed ID: 25799701)
1. B-type natriuretic peptide is a strong independent predictor of long-term outcome after transcatheter aortic valve implantation.
Gotzmann M; Czauderna A; Aweimer A; Hehnen T; Bösche L; Lind A; Kloppe A; Mügge A; Ewers A
J Heart Valve Dis; 2014 Sep; 23(5):537-44. PubMed ID: 25799701
[TBL] [Abstract][Full Text] [Related]
2. Pro B-type natriuretic peptide plasma value: a new criterion for the prediction of short- and long-term outcomes after transcatheter aortic valve implantation.
López-Otero D; Trillo-Nouche R; Gude F; Cid-Álvarez B; Ocaranza-Sanchez R; Alvarez MS; Lear PV; Gonzalez-Juanatey JR
Int J Cardiol; 2013 Sep; 168(2):1264-8. PubMed ID: 23280329
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of B-type natriuretic peptide to predict outcome of patients treated by transcatheter aortic valve implantation.
Kefer J; Beauloye C; Astarci P; Renkin J; Glineur D; Dekleermaeker A; Vanoverschelde JL
Am J Cardiol; 2010 Dec; 106(12):1782-6. PubMed ID: 21055712
[TBL] [Abstract][Full Text] [Related]
4. Effect of B-type natriuretic peptides on long-term outcomes after transcatheter aortic valve implantation.
Koskinas KC; O'Sullivan CJ; Heg D; Praz F; Stortecky S; Pilgrim T; Buellesfeld L; Jüni P; Windecker S; Wenaweser P
Am J Cardiol; 2015 Nov; 116(10):1560-5. PubMed ID: 26428025
[TBL] [Abstract][Full Text] [Related]
5. Comparison of brain natriuretic peptide plasma levels versus logistic EuroSCORE in predicting in-hospital and late postoperative mortality in patients undergoing aortic valve replacement for symptomatic aortic stenosis.
Pedrazzini GB; Masson S; Latini R; Klersy C; Rossi MG; Pasotti E; Faletra FF; Siclari F; Minervini F; Moccetti T; Auricchio A
Am J Cardiol; 2008 Sep; 102(6):749-54. PubMed ID: 18774001
[TBL] [Abstract][Full Text] [Related]
6. Elevation of B-Type Natriuretic Peptide at Discharge is Associated With 2-Year Mortality After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis: Insights From a Multicenter Prospective OCEAN-TAVI (Optimized Transcatheter Valvular Intervention-Transcatheter Aortic Valve Implantation) Registry.
Mizutani K; Hara M; Iwata S; Murakami T; Shibata T; Yoshiyama M; Naganuma T; Yamanaka F; Higashimori A; Tada N; Takagi K; Araki M; Ueno H; Tabata M; Shirai S; Watanabe Y; Yamamoto M; Hayashida K
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28710182
[TBL] [Abstract][Full Text] [Related]
7. Impact of B-type natriuretic peptide on short-term clinical outcomes following transcatheter aortic valve implantation.
O'Sullivan CJ; Stortecky S; Heg D; Jüni P; Windecker S; Wenaweser P
EuroIntervention; 2015 Feb; 10(10):e1-8. PubMed ID: 24429160
[TBL] [Abstract][Full Text] [Related]
8. Impact of lung diseases on morbidity and mortality after transcatheter aortic valve implantation: insights from spirometry and body plethysmography.
Gotzmann M; Knoop H; Ewers A; Mügge A; Walther JW
Am Heart J; 2015 Oct; 170(4):837-842.e1. PubMed ID: 26386809
[TBL] [Abstract][Full Text] [Related]
9. Different impact of aortic regurgitation assessed by aortic root angiography after transcatheter aortic valve implantation according to baseline left ventricular ejection fraction and N-terminal pro-B-type natriuretic peptide.
Kaneko H; Hoelschermann F; Schau T; Tambor G; Neuss M; Butter C
Cardiovasc Interv Ther; 2018 Jul; 33(3):232-238. PubMed ID: 28567700
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis.
Iwahashi N; Nakatani S; Umemura S; Kimura K; Kitakaze M
J Am Soc Echocardiogr; 2011 Sep; 24(9):984-91. PubMed ID: 21570253
[TBL] [Abstract][Full Text] [Related]
11. The evolution and prognostic value of N-terminal brain natriuretic peptide in predicting 1-year mortality in patients following transcatheter aortic valve implantation.
Elhmidi Y; Bleiziffer S; Piazza N; Ruge H; Krane M; Deutsch MA; Hettich I; Voss B; Mazzitelli D; Lange R
J Invasive Cardiol; 2013 Jan; 25(1):38-44. PubMed ID: 23293174
[TBL] [Abstract][Full Text] [Related]
12. Correlation of brain natriuretic peptide levels in patients with severe aortic stenosis undergoing operative valve replacement or percutaneous transcatheter intervention with clinical, echocardiographic, and hemodynamic factors and prognosis.
Ben-Dor I; Minha S; Barbash IM; Aly O; Dvir D; Deksissa T; Okubagzi P; Torguson R; Lindsay J; Satler LF; Pichard AD; Waksman R
Am J Cardiol; 2013 Aug; 112(4):574-9. PubMed ID: 23683951
[TBL] [Abstract][Full Text] [Related]
13. Impact of Preprocedural B-Type Natriuretic Peptide Levels on the Outcomes After Transcatheter Aortic Valve Implantation.
Abramowitz Y; Chakravarty T; Jilaihawi H; Lee C; Cox J; Sharma RP; Mangat G; Cheng W; Makkar RR
Am J Cardiol; 2015 Dec; 116(12):1904-9. PubMed ID: 26602075
[TBL] [Abstract][Full Text] [Related]
14. Long-term prognostic value and serial changes of plasma N-terminal prohormone B-type natriuretic peptide in patients undergoing transcatheter aortic valve implantation.
Ribeiro HB; Urena M; Le Ven F; Nombela-Franco L; Allende R; Clavel MA; Dahou A; Côté M; Laflamme J; Laflamme L; DeLarochellière H; DeLarochellière R; Doyle D; Dumont E; Bergeron S; Pibarot P; Rodés-Cabau J
Am J Cardiol; 2014 Mar; 113(5):851-9. PubMed ID: 24528616
[TBL] [Abstract][Full Text] [Related]
15. Assessment of left ventricular function with tissue Doppler echocardiography and of B-type natriuretic peptide levels in patients undergoing transcatheter aortic valve implantation.
Yüksel IO; Arslan S; Cagirci G; Koklu E; Ureyen CM; Bayar N; Kucukseymen S; Kus G; Guven R
Rev Port Cardiol; 2017 May; 36(5):377-383. PubMed ID: 28495181
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of QRS duration after transcatheter aortic valve implantation for aortic stenosis using the CoreValve.
Meguro K; Lellouche N; Yamamoto M; Fougeres E; Monin JL; Lim P; Mouillet G; Dubois-Rande JL; Teiger E
Am J Cardiol; 2013 Jun; 111(12):1778-83. PubMed ID: 23528030
[TBL] [Abstract][Full Text] [Related]
17. Two-year outcomes for patients with severe symptomatic aortic stenosis treated with transcatheter aortic valve implantation.
Codner P; Assali A; Dvir D; Vaknin-Assa H; Porat E; Shapira Y; Kupershmidt M; Bental T; Battler A; Sagie A; Kornowski R
Am J Cardiol; 2013 May; 111(9):1330-6. PubMed ID: 23415022
[TBL] [Abstract][Full Text] [Related]
18. Predictors of 1-year mortality in patients with aortic regurgitation after transcatheter aortic valve implantation: an analysis from the multicentre German TAVI registry.
Abdel-Wahab M; Zahn R; Gerckens U; Linke A; Sievert H; Schäfer U; Kahlert P; Hambrecht R; Sack S; Hoffmann E; Senges J; Schneider S; Richardt G;
Heart; 2014 Aug; 100(16):1250-6. PubMed ID: 24895354
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Outcomes for Patients With Severe Symptomatic Aortic Stenosis Treated With Transcatheter Aortic Valve Implantation.
Codner P; Orvin K; Assali A; Sharony R; Vaknin-Assa H; Shapira Y; Schwartzenberg S; Bental T; Sagie A; Kornowski R
Am J Cardiol; 2015 Nov; 116(9):1391-8. PubMed ID: 26342515
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of serial B-type natriuretic peptide measurement in transcatheter aortic valve replacement (from the PARTNER Trial).
O'Neill BP; Guerrero M; Thourani VH; Kodali S; Heldman A; Williams M; Xu K; Pichard A; Mack M; Babaliaros V; Herrmann HC; Webb J; Douglas PS; Leon MB; O'Neill WW
Am J Cardiol; 2015 May; 115(9):1265-72. PubMed ID: 25863422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
